Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.09
-0.1400-0.81%
Post-market: 17.02-0.0670-0.39%17:39 EDT
Volume:901.59K
Turnover:15.48M
Market Cap:3.16B
PE:-10.55
High:17.35
Open:17.12
Low:16.96
Close:17.23
52wk High:45.30
52wk Low:16.24
Shares:184.69M
Float Shares:81.38M
Volume Ratio:0.76
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6200
EPS(LYR):-1.6200
ROE:-29.06%
ROA:-5.01%
PB:3.15
PE(LYR):-10.55

Loading ...

Legend Biotech : Barclays Cuts Target Price to $80 From $90

THOMSON REUTERS
·
Feb 04

Legend Biotech (LEGN) Gets a Buy from Barclays

TIPRANKS
·
Feb 04

Legend Biotech Appoints Robin Meng to Board as Li Zhu and Yau Wai Man Philip Resign

Reuters
·
Jan 26

Genscript Chairman Joins Board of Nasdaq-Listed Associate Legend Biotech

TIPRANKS
·
Jan 23

GENSCRIPT BIO (01548) Appoints Meng Jiange to Legend Biotech's Board

Stock News
·
Jan 23

Could New FDA MRD Guidance Quietly Redefine Legend Biotech’s (LEGN) Multiple Myeloma Ambitions?

Simply Wall St.
·
Jan 23

TD Cowen Downgrades Legend Biotech to Hold From Buy, Adjusts Price Target to $21 From $62

MT Newswires Live
·
Jan 22

Goldman Sachs Keeps Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Jan 22

Legend Biotech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 22

Legend Biotech: Undervalued CARVYKTI Leader Offering a Compelling Buy Opportunity Despite Transient Setback

TIPRANKS
·
Jan 22

Legend Biotech price target lowered to $50 from $60 at H.C. Wainwright

TIPRANKS
·
Jan 22

U.S. RESEARCH ROUNDUP-Cencora, Crocs, Teledyne Technologies

Reuters
·
Jan 22

Hong Kong Stock Movement | GENSCRIPT BIO (01548) Plummets Over 7%, Affiliate Legend Biotech's Shares Tumble More Than 11% Overnight

Stock News
·
Jan 22

Legend Biotech downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jan 22

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jan 22

Legend Biotech Down Over 14%, on Track for Record Low Close -- Data Talk

Dow Jones
·
Jan 22

Legend Biotech falls -10.5%

TIPRANKS
·
Jan 21

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Legend Biotech (LEGN)

TIPRANKS
·
Jan 21

Legend Biotech Highlights New CARVYKTI Clinical Data at 2026 Tandem Meetings

Reuters
·
Jan 21

Legend Biotech Reports Preliminary $555 Million CARVYKTI Sales for Q4 2025

Reuters
·
Jan 21